Table 3 Power calculations–minimum detectable effects
Outcomes: proportion of population | Current estimate | Intervention group target | Minimum detectable difference (proportion) |
|---|---|---|---|
Testing; tested in past 12Â months | 35% | 60% | 19% |
Linkage; undergoing CD4 staging within 3Â months of positive test | 65% | 85% | 18% |
Linkage; eligible for ART who initiate treatment within 3Â months | 60% | 80% | 19% |
Retention; HIV positive who remain in care at 12Â months | 50% | 70% | 19% |